Averting a Judicial Showdown: GSK's Preemptive Strike in Zantac Cancer Lawsuit

This article revolves around the British pharmaceutical company GlaxoSmithKline (GSK) settling a lawsuit in the United States concerning its heartburn medication, Zantac. The lawsuit, brought forward by California resident James Goetz, claimed that Zantac had caused him to develop bladder cancer. Before the case could reach trial, GSK agreed to an undisclosed settlement, precluding what would have been the first judicial test of claims that Zantac causes cancer.